BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 236 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,076,924 | 27.82% |
| Prosight Management, LP | 5,000,000 | $35,200,000 | 5.27% |
| Saturn V Capital Management LP | 954,856 | $6,722,186 | 3.73% |
| ORACLE INVESTMENT MANAGEMENT INC | 555,522 | $3,910,875 | 2.88% |
| Kynam Capital Management, LP | 2,848,197 | $20,051,307 | 2.76% |
| TANG CAPITAL MANAGEMENT LLC | 2,450,000 | $17,248,000 | 2.54% |
| AlphaCentric Advisors LLC | 570,000 | $4,012,800 | 2.23% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 760,904 | $5,356,764 | 1.66% |
| Eversept Partners, LP | 2,372,113 | $16,699,676 | 1.40% |
| Avoro Capital Advisors LLC | 12,055,000 | $84,867,200 | 1.15% |
| DAFNA Capital Management LLC | 569,000 | $4,005,760 | 1.10% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,872,964 | $13,185,669 | 0.75% |
| BRAIDWELL LP | 2,791,880 | $19,654,835 | 0.64% |
| Sarissa Capital Management LP | 775,000 | $5,456,000 | 0.54% |
| Baker Brothers Advisors | 12,710,818 | $89,484,159 | 0.52% |
| Ghost Tree Capital, LLC | 200,000 | $1,408,000 | 0.46% |
| Rock Springs Capital Management LP | 2,497,193 | $17,580,239 | 0.42% |
| Eventide Asset Management | 1,970,000 | $13,868,800 | 0.23% |
| HighVista Strategies LLC | 68,725 | $483,824 | 0.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,322,000 | $9,306,880 | 0.20% |
External links
This page lists BIOCRYST PHARMACEUTICALS INC's shareholders in Q2 2023. To view BIOCRYST PHARMACEUTICALS INC's shareholder history, click here.